-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 NdqXm0l3oyeBWvjVZ8fpA3jgeQhwR+tGbBm8lDUVCeO5kuOH5aNZlybPFxQqaX4a
 zgUj1nUn5lkLTr9xVjn4/A==

<SEC-DOCUMENT>0000724910-10-000022.txt : 20100916
<SEC-HEADER>0000724910-10-000022.hdr.sgml : 20100916
<ACCEPTANCE-DATETIME>20100916160617
ACCESSION NUMBER:		0000724910-10-000022
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20100913
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20100916
DATE AS OF CHANGE:		20100916

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NVE CORP /NEW/
		CENTRAL INDEX KEY:			0000724910
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				411424202
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-12196
		FILM NUMBER:		101076102

	BUSINESS ADDRESS:	
		STREET 1:		11409 VALLEY VIEW ROAD
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344
		BUSINESS PHONE:		9528299217

	MAIL ADDRESS:	
		STREET 1:		11409 VALLEY VIEW ROAD
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PREMIS CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>sjm8k-10.htm
<DESCRIPTION>AMENDMENT NO. 3 TO CURRENT REPORT ON FORM 8-K
<TEXT>
<p align="center"> <font face="Times New Roman, Times, serif" size="5"><b>UNITED STATES<br>
 SECURITIES AND EXCHANGE COMMISSION</b></font><b><font face="Times New Roman, Times, serif" size="2"><br>
 Washington, D.C.&nbsp;&nbsp;20549</font></b></p><p align="center"><b><font face="Times New Roman, Times, serif" size="2"> <font size="5">FORM
 8-K/A</font></font></b></p><p align="center"><b><font face="Times New Roman, Times, serif" size="3">(Amendment No. 3)<br>
CURRENT REPORT<br>
</font></b><font face="Times New Roman, Times, serif" size="3"><b>Pursuant to
Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></font></p><p><font face="Times New Roman, Times, serif" size="2"><br>
Date of Report (Date of earliest event reported)&nbsp;&nbsp;<b><u>September 13, 2010</u></b><br>
</font></p><div align="center"><b><font size="6" face="Arial, Helvetica, sans-serif"><img src="nve-logo.gif" width="276" height="54"><br>
NVE Corporation</font></b><font face="Times New Roman, Times, serif" size="2"><br>
(Exact name of registrant as specified in its charter)</font></div><font face="Times New Roman, Times, serif" size="2">
<div>
<p>&nbsp;</p></div></font>
<div align="center"></div><table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td width="33%">
<p align="center"><font face="Times New Roman, Times, serif"><b><font size="2" ><u>Minnesota</u></font></b></font></p></td><td width="33%">
<div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>000-12196</u></b></font>
</div></td><td>
<p align="center"><b><font size="2" face="Times New Roman"><u>41-1424202</u></font></b></p></td></tr>
<tr>
<td width="33%">
<p align="center"><font size="2" face="Times New Roman, Times, serif">(State or other jurisdiction of incorporation)</font></p></td><td width="33%">
<div align="center"><font face="Times New Roman, Times, serif" size="2">(Commission File Number) </font></div></td><td>
<div align="center"><font size="2" face="Times New Roman, Times, serif">(IRS Employer Identification No.)</font></div></td></tr>
</table><br>
<br>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td width="25%">
<p align="center"><font face="Times New Roman, Times, serif"><b><font size="2">&nbsp;</font></b></font></p></td><td width="50%">
<p align="center"><font size="2"><b><u>11409 Valley View Road, Eden Prairie, Minnesota</u></b></font></p></td><td>
<p align="center"><font size="2"><b><font face="Times New Roman" ><u>55344</u></font></b></font></p></td></tr>
<tr>
<td width="25%">
<p align="center"><font size="2">&nbsp;</font></p></td><td width="50%">
<p align="center"><font size="2" face="Times New Roman, Times, serif">(Address of principal executive offices)</font></p></td><td>
<p align="center"><font size="2">(Zip Code)</font></p></td></tr>
</table><br>
<font size="2" face="Times New Roman, Times, serif"> Registrant&#146;s telephone
number, including area code <b><u>(952) 829-9217</u></b><br>
</font>
<p align="center"><font face="Times New Roman, Times, serif" size="2"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
 </font><font face="Times New Roman, Times, serif" size="2">(Former name or former
 address, if changed since last report.)</font></p><p><font face="Times New Roman, Times, serif" size="2">Check the appropriate box
 below if the Form 8-K filing is intended to simultaneously satisfy the filing
 obligation of the registrant under any of the following provisions (see General
 Instruction A.2. below):</font></p><p><font face="Times New Roman, Times, serif" size="2">[&nbsp;&nbsp;] Written
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p><p><font face="Times New Roman, Times, serif" size="2">[&nbsp;&nbsp;] Soliciting
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p><p><font face="Times New Roman, Times, serif" size="2">[&nbsp;&nbsp;] Pre-commencement communications
 pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p><p><font face="Times New Roman, Times, serif" size="2">[&nbsp;&nbsp;] Pre-commencement communications
 pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p><hr>
 <br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman, Times, serif" size="2"><b>Explanatory Note</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment Number 3 to Form 8-K is being filed
to disclose a third amendment to our Supplier Partnering Agreement dated January&nbsp;3, 2006, as amended by Amendment Number&nbsp;1 to the Agreement dated September 6, 2007 and Amendment Number&nbsp;2 dated December 15, 2009, by and between Pacesetter, Inc.,
a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management
Division (&#147;St. Jude&#148;), and us. <br>
<br><br>
<b>Item 1.01 Entry into a Material Definitive Agreement</b><br>
<br>
<b><i>General information</i></b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We supply spintronic sensors to St. Jude intended
for use in medical devices under the Agreement as amended.<br>
<br>
<b><i>Description of the Terms and Conditions of the Amendment</i></b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On September 13, 2010 we executed Amendment
Number 3 to the Agreement, which extends the term of the
Agreement as amended through December 31, 2011 and modifies the unit price.
Amendment Number&nbsp;3 is filed herein as Exhibit 10.5 to this Current Report on Form 8-K/A.</font><p>&nbsp;</p><p>&nbsp;</p><p align="center"><font face="Times New Roman, Times, serif" size="2">2</font><hr><br clear="all" style="page-break-before:always;"><p><font face="Times New Roman, Times, serif" size="2"><b>Item 9.01 Financial Statements and Exhibits</b><br>
<br>
</font>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td width="1%">
<div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>Exhibit&nbsp;#</u></b></font></div></td><td width="88%">
<div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>Description</u></b></font></div></td></tr>
<tr>
<td colspan="2"><font face="Times New Roman, Times, serif" size="2"></font></td></tr>
<tr>
<td valign="top">
<font face="Times New Roman, Times, serif" size="2">&nbsp;&nbsp;10.1</font></td><td><font face="Times New Roman, Times, serif" size="2">Indemnification
Agreement by and between Pacesetter, Inc., a St. Jude Medical Company,
d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and the company
(incorporated by reference to our Current Report on Form 8-K filed September 27, 2005).<br>
&nbsp;
</font></td></tr>
<tr>
<td valign="top">
<font face="Times New Roman, Times, serif" size="2">&nbsp;&nbsp;10.2+</font></td><td><font face="Times New Roman, Times, serif" size="2">Supplier Partnering Agreement by and between Pacesetter, Inc., a St. Jude Medical
Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and
the company (incorporated by reference to our Current Report on Form 8-K
filed January 4, 2006).<br>
&nbsp;
</font></td></tr>
<tr>
<td valign="top">
<font face="Times New Roman, Times, serif" size="2">&nbsp;&nbsp;10.3+</font></td><td><font face="Times New Roman, Times, serif" size="2">Amendment Number 1 dated September 6, 2007 to Supplier Partnering Agreement between Pacesetter, Inc.,
a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management
Division, and the company (incorporated by reference to our Current Report on Form 8-K/A
filed September 10, 2007).<br>
&nbsp;
</font></td></tr><tr>
<td valign="top">
<font face="Times New Roman, Times, serif" size="2">&nbsp;&nbsp;10.4+</font></td><td><font face="Times New Roman, Times, serif" size="2">Amendment Number 2 dated December 15, 2009 to Supplier Partnering Agreement between Pacesetter, Inc.,
a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management
Division, and the company (incorporated by reference to our Current Report on Form 8-K/A
filed December 18, 2009).<br>&nbsp;</font></td></tr>
<tr>
<td valign="top">
<font face="Times New Roman, Times, serif" size="2">&nbsp;&nbsp;10.5+</font></td><td><font face="Times New Roman, Times, serif" size="2">Amendment Number 3 dated September 13, 2010 to Supplier Partnering Agreement between Pacesetter, Inc.,
a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management
Division, and the company (filed with this Current Report on Form 8-K/A).</font></td></tr>
</table><font face="Times New Roman, Times, serif" size="2"><br>
+Confidential portions of this exhibit have been deleted and filed separately with the SEC under a
request for confidential treatment pursuant to Rule 24b-2 or Rule 406.</font>
<p>&nbsp;</p><p>&nbsp;</p><p align="center"><font face="Times New Roman, Times, serif" size="2">3</font>
<hr><br clear="all" style="page-break-before:always;"><font face="Times New Roman, Times, serif" size="2"><div align="center"><b>SIGNATURE</b></div><br><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
<p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td width="33%" valign="top">
<font face="Times New Roman, Times, serif" size="2">Date&nbsp;&nbsp;<b><u>September&nbsp;16,&nbsp;2010</u></b>
</font>
</td><td align="center" width="34%"><font face="Times New Roman, Times, serif" size="2"><b><u>NVE CORPORATION<br>
</u></b>(Registrant)<br>
<br>
<u>&nbsp;/s/ DANIEL A. BAKER</u><br>
Daniel A. Baker<br>
President&nbsp;and&nbsp;Chief&nbsp;Executive&nbsp;Officer</font></td><td width="33%"></td></tr>
</table><p>&nbsp;</p><p>&nbsp;</p><p align="center"><font face="Times New Roman, Times, serif" size="2">4</font><hr>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>sjm-a3.htm
<DESCRIPTION>AMENDMENT NO. 3 TO SUPPLIER AGREEMENT BETWEEN ST. JUDE AND THE COMPANY
<TEXT>
<font size="2" face="Times New Roman, Times, serif"><b>A CONFIDENTIAL PORTION OF
THIS EXHIBIT HAS BEEN REPLACED WITH ASTERISKS AND FILED SEPARATELY WITH THE SEC
UNDER A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 OR RULE 406.</b>
<br>
<br>
NVE and Pacesetter Confidential<br>
&nbsp;<br>
&nbsp;<br>
<div align="center"><b><u>Amendment No. 3 to Supplier Partnering Agreement</u></b></div><br>
&nbsp;<br>
This Amendment No. 3 to Supplier Partnering Agreement dated January&nbsp;1, 2006 (as previously amended, the &#147;Agreement&#148;) by and between Pacesetter, Inc. (d/b/a St. Jude Medical CRMD), a St. Jude Medical
Company, 15900 Valley View Court, Sylmar, California&nbsp;&nbsp;91392-9221 (&#147;Buyer&#148;);
and NVE Corporation, 11409 Valley View Road, Eden Prairie, MN&nbsp;&nbsp;55344-3617 (&#147;Seller&#148;)
is executed by and between Buyer and Seller.<br>
<br>
1. <u>Extension of Term of Agreement</u>.<br>
Section 1 of the Agreement is amended so that the term of this
Agreement will continue until December 31, 2011.<br>
<br>
2. <u>Changes in Unit Price</u><br>
Attachment 1 of the Agreement shall be amended to reflect a 2011 price of **.<br>
<br>
3. Escrow Agreement<br>
Buyer and Seller shall negotiate in good faith towards execution of a mutually satisfactory technology escrow agreement to provide for the retention, administration and controlled access of Seller&#146;s product proprietary technology under certain circumstances.<br>
<br>4. Except as expressly amended above, all other terms and conditions of the Agreement will continue in full
force and effect without change or modification.<br>
<br>
IN WITNESS OF THIS AGREEMENT, the parties have signed below by their authorized officers, effective as of the later date below:<br>
&nbsp;</font>
<table style="font-size: 10pt; font-family: Times New Roman;" border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td width="50%"><b>PACESETTER, INC.</b></td><td><b>NVE Corporation</b></td></tr>
<tr>
<td>&nbsp;</td><td></td></tr>
<tr>
<td>By:&nbsp;<u>&nbsp; /s/ JEFF CHATEAU&nbsp;</u></td><td>By:&nbsp;<u>&nbsp;/s/ DANIEL A. BAKER&nbsp;&nbsp;&nbsp;</u>
</td></tr>
<tr>
<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jeff Chateau
</td><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Daniel A. Baker</td></tr>
<tr>
<td>&nbsp;</td><td></td></tr>
<tr>
<td>Title:&nbsp;<u>&nbsp;V.P, Supply Line&nbsp;&nbsp;</u>
</td><td>Title:&nbsp;<u>&nbsp;President&nbsp;&amp;&nbsp;CEO&nbsp;&nbsp;</u></td></tr>
<tr>
<td>&nbsp;</td><td></td></tr>
<tr>
<td>Date:&nbsp;<u>&nbsp;9-8-10&nbsp;</u>
</td><td>Date:&nbsp;<u>&nbsp;9/13/10&nbsp;</u>
</td></tr>
</table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><table style="font-size: 10pt; font-family: Times New Roman;" border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td width="33%">Confidential</td><td align="center">Page 1</td><td align="right" width="33%">9/8/2010</td></tr>
</table>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>nve-logo.gif
<DESCRIPTION>NVE CORPORATION LOGO
<TEXT>
begin 644 nve-logo.gif
M1TE&.#EA%`$V`+,```!&K0DW>0<C3$!.8GAY>O___^+BXK2TM```````````
M`````````````````````"P`````%`$V```$_[#(20M!..M3NY>7I@E<-8CB
M\*UL@:*5(<QT;=]X?I?4\?[`H'!(+!I?O,\`P&PV`X36BN"L"@P=0J#J%$B_
MH"V7>:T<Q..T>MW%5K3LN'Q.K]NY999@G0=/EFE>'6=J?7X>,FH!*F]WCET>
M5(^3E)5W@BN$BE&'$GMIC#&?8P%)G11P@6X4@)9TH:RNLK.SL)%H@:>:7%`?
MH[R<IQ2):;T=O[3%P13(R<[/FRVMA:92J;S5$M-<ML+7>*L3Q-#8@[CDZ.2E
M+<UCRU_;;1^2H,+#[4SKYNE6X6'\`)\9ZC".CS]VA::<@V1/V\(FW4`$;(()
MU<2+LBIZV+7&V)>"5?_>]7A(YJ"?`_@`D%"",6(\C##K1+0X1R,+CDX\>DBI
M3]C+?#,+I`1PQ$BVHDB3*ETJ)%NLFDZSD.RY<XU(,"@+F2P`LDK0AF##BAU+
M]EB=JQY^JI2VYJN>:!]PYHQ:MJ[=NWBY#@7W):5;>F/<QB6I<JL%@WD3*U[<
M4&Y'M/?40);@F,RIKD\FJUW+N+/GSR8N2:FL$Q%/NK>TOI4,NK7KQ)L#H09<
MA:HO1:A%X;Y)V/;KW\"%[:W'0JW-M%8/?;/28KF\X-"C?ZG,9F`%OU]H>_6#
MF<QL/M+#BY=:C"?D[@`F3W!.T0][`(ND#!4\OOYGXP,('Z<\53W_A!^E9)W_
M;LK89R!T`J+GFT2J!+B;%/D5V`)U`QYHX6+HJ;#93,;Y8=YH"5JCWX4D?D9=
M%!2:A!T8F_FG5FDL%<*4")/-:..-./[P73$E?&@&8?ZMU]:$^AG&3$#G#1?3
MDK6I9YP;[W&&RE2Y34`A0A*V@!XM"_['Y)=Q=#F!@.*<UDB#8*!7H04C3D<8
M+6M&">:<^Y6I!BS:.6%+AX>8:1HU8.0I4'%S%DI<)OWU$*($&7;R(EI1TJ<-
MDJL9:BD3Z@D*GRD^%G!B)YJF]Z=L'@($HYV76GKJ4V,,%"4F[XDY#V$1Q1HD
MHTI:LB9UJ<*T4J5X$.3GDYU<26"K1OX(4)V']6HH_[.>`ID:<61VHJ8_$9)R
M*X.!Y%ACCN"&N]1LB0Z28*.G^$G9HBP.6>*[BKWHE'F?GO(HJ\!T,M2V\/;;
M)X`;Z:>IK%,DMR[`::KK[\)AH3LJ*>P>0ETH`E8YI6H,9]R8M`H5@K#$;4Y\
M2JC0:FSRK#RRL.6=#9U;L;WNGBPS/!BO$%L:_(;&8ZR27F?PS$"O4"UO=A!,
MJ&018]6;Q4%G[/`**_-ESZOE@EIDTUB/Q)J(=91,=#$U'[*9UUDS/'"54>L)
M5MI-VC-?V6432S,=.9ME!]G"_@QWT$./]N9<8=U<&]/*%B,N`H@<KOCB01#)
M<JERK!FH'3V3-]%Q@CN[;)!S56?WMV5AR6D%X3I/=%6NFJ>3Z8,)RU'Y8'/$
MU_)%,+*=NCKJ)0UAF'57%7FR*J/NBF^\WLZ/K&KJ\K?1?<FQJM(7'2>Z\>A`
M6Z^^U0$_=_9@A?J,2]0S^5?G[KV)=W.\!X[1Z>$OZ23KAVSY.J+<@R6\);7?
<W_[PN0-QO@E!Z%WBFM(PQNEH$`9,H`%1$P$`.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
